L-Proline reduces IgG dimer content and enhances the stability of intravenous immunoglobulin (IVIG) solutions
- PMID: 19931468
- DOI: 10.1016/j.biologicals.2009.09.002
L-Proline reduces IgG dimer content and enhances the stability of intravenous immunoglobulin (IVIG) solutions
Abstract
Liquid intravenous immunoglobulin (IVIG) products offer improved convenience in preparation but often lack sufficient stability to allow room temperature storage. Furthermore, clinical tolerability may be affected due to formation of idiotype/anti-idiotype IgG dimers and/or aggregates. Here we report on the development of a 10% IVIG formulation with optimized stability achieved by the use of l-proline. The stability of concentrated liquid IVIG was strongly pH dependent. Aggregate formation, yellowish discoloration of the solution and loss of anti-hepatitis B surface antigen (HBs) antibody activity was minimal at intermediate pH (pH 4.8-5.3). Fragmentation of IgG was highest at low pH (pH 4.1). Idiotype/anti-idiotype IgG dimer formation was highest at neutral pH and was reduced with decreasing pH. The presence of L-proline further improved stability by inhibiting protein aggregation, reducing loss of anti-HBs antibody activity and decreasing coloring, particularly compared with glycine formulations. The IgG dimer content was up to 30% lower in solutions containing L-proline compared with those containing glycine or other stabilizers. In conclusion, a weakly acidic pH of approximately 5 and L-proline as stabilizer are optimal conditions for long-term stability of a liquid IVIG. L-proline, an amphiphilic, naturally occurring amino acid, is superior to glycine in restricting IgG dimer formation.
Copyright 2009 The International Association for Biologicals. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
The effect of solvent environment on the conformation and stability of human polyclonal IgG in solution.Biologicals. 2006 Mar;34(1):5-14. doi: 10.1016/j.biologicals.2005.06.007. Epub 2005 Sep 15. Biologicals. 2006. PMID: 16168667
-
Stability over 36 months of a new liquid 10% polyclonal immunoglobulin product (IgPro10, Privigen) stabilized with L-proline.Vox Sang. 2009 Apr;96(3):219-25. doi: 10.1111/j.1423-0410.2008.01143.x. Epub 2009 Jan 7. Vox Sang. 2009. PMID: 19207169
-
Local tolerance and stability up to 24 months of a new 20% proline-stabilized polyclonal immunoglobulin for subcutaneous administration.Biologicals. 2011 Jan;39(1):43-9. doi: 10.1016/j.biologicals.2010.11.004. Epub 2011 Jan 22. Biologicals. 2011. PMID: 21257320
-
Interactions between immunoglobulin G molecules.Immunol Lett. 2010 Aug 16;132(1-2):1-5. doi: 10.1016/j.imlet.2010.06.006. Epub 2010 Jun 18. Immunol Lett. 2010. PMID: 20600325 Review.
-
The new generation of liquid intravenous immunoglobulin formulations in patient care: a comparison of intravenous immunoglobulins.Postgrad Med. 2010 Sep;122(5):176-84. doi: 10.3810/pgm.2010.09.2214. Postgrad Med. 2010. PMID: 20861601 Review.
Cited by
-
Efficacy and tolerability of 16% subcutaneous immunoglobulin compared with 20% subcutaneous immunoglobulin in primary antibody deficiency.Clin Exp Immunol. 2015 Sep;181(3):441-50. doi: 10.1111/cei.12623. Epub 2015 Jul 7. Clin Exp Immunol. 2015. PMID: 25761372 Free PMC article. Clinical Trial.
-
Design and Evaluation of the Highly Concentrated Human IgG Formulation Using Cyclodextrin Polypseudorotaxane Hydrogels.AAPS PharmSciTech. 2015 Dec;16(6):1290-8. doi: 10.1208/s12249-015-0309-x. Epub 2015 Mar 17. AAPS PharmSciTech. 2015. PMID: 25776984 Free PMC article.
-
Immune globulin subcutaneous (human), 20% liquid.P T. 2010 Aug;35(8 Section 2):2-4. P T. 2010. PMID: 20842207 Free PMC article. No abstract available.
-
Biochemical Characterization of a New 10% IVIG Preparation [IgG Next Generation (BT595)/Yimmugo®] Obtained from a Manufacturing Process Preserving IgA/IgM Potential of Human Plasma.Drugs R D. 2023 Sep;23(3):245-255. doi: 10.1007/s40268-023-00430-w. Epub 2023 Jul 19. Drugs R D. 2023. PMID: 37466834 Free PMC article.
-
Privigen immune globulin intravenous (human), 10% liquid.P T. 2011 Aug;36(8 Section 2):2-31. P T. 2011. PMID: 21935292 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources